comparemela.com
Latest Breaking News On - Endocrine business unit for mannkind corporation - Page 1 : comparemela.com
MannKind Corporation Announces Agreement to Acquire V-Go®
The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions DANBURY, Conn. and WESTLAKE.
United-states
Brazil
Alejandro-galindo
Michael-castagna
Adam-steensberg
Zealand-pharma
Endocrine-business-unit-for-mannkind-corporation
Mannkind-corporation
Mannkind-corporation-nasdaq
Kind-corporation
Chief-executive-officer
Executive-vice-president
MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand ...
The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions
United-states
Brazil
Rose-alinaya
Christie-iacangelo
Alejandro-galindo
Michael-castagna
Adam-steensberg
Zealand-pharma
Endocrine-business-unit-for-mannkind-corporation
Mannkind-corporation
Corporate-communications
Mannkind-corporation-nasdaq
MannKind Corp. To Acquire V-Go From Zealand Pharma
COPENHAGEN (dpa-AFX) - MannKind Corporation (MNKD) has entered into an agreement with Zealand Pharma A/S (ZEAL) to acquire V-Go for $10 million, with additional sales-based milestones plus the
Copenhagen
Køavn
Denmark
Alejandro-galindo
Zealand-pharma
Mannkind-corporation
Endocrine-business-unit-for-mannkind-corporation
Kind-corporation
Executive-vice-president
Endocrine-business-unit
Mannkind
Orp
MannKind Corporation Announces Agreement to Acquire V-Go Insulin Delivery Device From Zealand Pharma
17.05.2022 - The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 17, 2022 (GLOBE NEWSWIRE) - MannKind Corporation (Nasdaq: MNKD), a . Seite 1
Alejandro-galindo
Zealand-pharma
Adam-steensberg
Endocrine-business-unit-for-mannkind-corporation
Chief-executive-officer
Executive-vice-president
Endocrine-business-unit
vimarsana © 2020. All Rights Reserved.